quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:46:23·9d
INSIDERFiling
Jyong Biotech Ltd. logo

SEC Form 3 filed by new insider Zhang Wei (Vivi)

MENS· Jyong Biotech Ltd.
Health Care
Original source

Companies

  • MENS
    Jyong Biotech Ltd.
    Health Care

Related

  • INSIDER15d
    SEC Form 3 filed by new insider Kuo Fu-Feng
  • INSIDER22d
    SEC Form 3 filed by new insider Hsu Ming Tsan
  • INSIDER22d
    SEC Form 3 filed by new insider Hsu Feng-Lin
  • INSIDER22d
    SEC Form 3 filed by new insider Hsu Feng-Lin
  • INSIDER22d
    SEC Form 3 filed by new insider Fan Hung-Shu
  • INSIDER22d
    SEC Form 3 filed by new insider Chi Pang-Chieh
  • PR28d
    Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2
  • PR70d
    Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022